BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27726027)

  • 1. Mesenchymal stem cells moderate immune response of type 1 diabetes.
    Xv J; Ming Q; Wang X; Zhang W; Li Z; Wang S; Li Y; Li L
    Cell Tissue Res; 2017 May; 368(2):239-248. PubMed ID: 27726027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
    Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
    Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
    Bhonde RR; Sheshadri P; Sharma S; Kumar A
    Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.
    Katuchova J; Harvanova D; Spakova T; Kalanin R; Farkas D; Durny P; Rosocha J; Radonak J; Petrovic D; Siniscalco D; Qi M; Novak M; Kruzliak P
    Endocr Pathol; 2015 May; 26(2):95-103. PubMed ID: 25762503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-based therapy for type 1 diabetes.
    Wu H; Mahato RI
    Discov Med; 2014 Mar; 17(93):139-43. PubMed ID: 24641956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes.
    Nojehdehi S; Soudi S; Hesampour A; Rasouli S; Soleimani M; Hashemi SM
    J Cell Biochem; 2018 Nov; 119(11):9433-9443. PubMed ID: 30074271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
    Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
    Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus.
    Li L; Li F; Gao F; Yang Y; Liu Y; Guo P; Li Y
    Cell Tissue Res; 2016 May; 364(2):345-55. PubMed ID: 26650464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of mesenchymal stromal cells in pancreatic islet transplantation.
    Hematti P; Kim J; Stein AP; Kaufman D
    Transplant Rev (Orlando); 2013 Jan; 27(1):21-9. PubMed ID: 23290684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells ameliorate oxidative stress-induced islet endothelium apoptosis and functional impairment via Wnt4-β-catenin signaling.
    Wang L; Qing L; Liu H; Liu N; Qiao J; Cui C; He T; Zhao R; Liu F; Yan F; Wang C; Liang K; Guo X; Shen YH; Hou X; Chen L
    Stem Cell Res Ther; 2017 Aug; 8(1):188. PubMed ID: 28807051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
    Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
    Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes?
    Sariboyaci AE; Demircan PC; Gacar G; Unal ZS; Erman G; Karaoz E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):179-89. PubMed ID: 25014767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.